Preclinical cancer treatment developer falls most in 6 weeks on share sales to raise US$302 millionhttps://buff.ly/2Lj5XUT
0 replies
1 retweet
1 like
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.